Toimialayhteisöt

 

This document defines a maturity model and gives guidance on the evaluation criteria and methodology for evaluation of the quality of online learning across four key practice domains:

- online learning environment;

-  learner support;

-  learning and assessment tasks;

-  learning resources.

 

The scope of this document includes the following:

— maturity model definition;

— principles of evaluation questionnaires for maturity model components; — guidance for a maturity model evaluation method.

 

This document: — specifies the required processes implemented in the engineering activities that result in requirements for systems and software products (including services) throughout the life cycle; — provides guidelines for applying the requirements and requirements-related processes described in ISO/IEC/IEEE 15288 and ISO/IEC/IEEE 12207; — specifies the required information items produced through the implementation of the requirements processes; — specifies the required contents of the required information items; — provides guidelines for the organization of the required and related information items. This document is applicable to: — those who use or plan to use ISO/IEC/IEEE 15288 and ISO/IEC/IEEE 12207 on projects dealing with human-made systems, software-intensive systems, software and hardware products, and services related to those systems and products, regardless of the project scope, product(s), methodology, size or complexity; — those who use or plan to use ISO/IEC/IEEE 15289 on projects dealing with human-made systems, software-intensive systems, software and hardware products and services related to those systems and products, regardless of the project scope, product(s), methodology, size or complexity.

 

This document defines terms relating to the classification of road vehicle collisions, concentrating on configuration aspects. This document focuses on terminology for classification of vehicle-vehicle collisions and vehicle-obstacle collisions and does not include collisions with vulnerable road users. NOTE Additional terms and definitions on road vehicle accidents are given in ISO 12353-1.

 

This document describes methods for calibrating the optical components and flowrates of a BFPC, which is used to count microbiological (or autofluorescent) particles suspended in a known volume of air. Routine calibration of a BFPC focuses on maintaining the long-term technical integrity of optical measurements, spanning from the initial product development through the instruments's expected lifetime. The measurement principle of a BFPC is single particle laser-induced fluorescence (SP-LIF). Depending on the BFPC model, single-particle light scattering (SP-LS) measurements may also be performed. The particle size range measured by a BFPC typically span from 0,3 µm to 100 µm in diameter. The following parameters are within the scope of this document: Fluorescence intensity — Light scattering intensity (if applicable) — Flow rate (s) False counts — Counting efficiency of BFPC False positive rates — Counting efficiency of SP-LS system (if applicable)

 

This document specifies the requirements for respiratory protective devices for use by workers during response to incidents involving chemical, biological radiological or nuclear (CBRN) materials used with intent to cause harm or in cases of accidental release outside traditional hazardous materials response categories. For the purposes of this document, all incidents described here are named CBRN incidents. This document is applicable to RPD for use by personnel in the following roles: — First responders: including police, fire service, emergency medical, search and rescue, sampling and detection teams. — Workers needed for specific roles during response (utility, transportation, service continuity). — Medical personnel working with casualties of CBRN incidents. — Responders to release incidents involving nuclear materials. — Non-emergency but CBRN-related roles. — Workers in need of protection during escape from a CBRN or radiological release incident. — Workers in need of protection from nuclear materials. The requirements for RPD use by the following groups are not addressed by this document: — Military personnel outside of first responder roles. — Children. — Animals. Requirements for the following are not covered by this document: — Collective protection systems including ventilated casualty/body bags. — Methods of and criteria for decontamination of RPD. — Disposal of used equipment. This document is focused on respiratory protection requirements, but it is recognised that CBRN RPD are always used as part of an ensemble with protective clothing. The total ensemble effectiveness is not covered by this document.

 

This document specifies requirements and gives recommendations for next generation sequencing (NGS) workflows for in vitro diagnostics and biomedical research. This document covers the pre-examination processes including human DNA (somatic and germline) isolation, sequencing library preparation, sequencing, sequence analysis and reporting of the examined sequences for diagnostic purposes from isolated DNA from, e.g. formalin-fixed and paraffin embedded tissues, fresh frozen tissues, fine needle aspirates (FNA), whole blood, circulating tumour cells (CTCs), exosomes and other extracellular vesicles, circulating cell free DNA from plasma, and DNA from saliva. NOTE 1 Typical applications include, but are not limited to, NGS for oncology, pharmacogenomics and clinical genetics; approaches include panels (e.g. disease panels, exome panels, target gene panels and in silico panels), exome and whole genome sequencing, as well as certain epigenetic and certain single-cell analyses. This document addresses in vitro diagnostic examinations including laboratory developed examinations and is applicable to medical laboratories, molecular pathology laboratories and molecular genetic laboratories, in vitro diagnostic developers and manufacturers, biobanks and institutions and organizations performing biomedical research or sequencing services. This document is not applicable for in situ sequencing, DNA-mediated protein sequencing, forensic sequencing, sequencing of pathogens or microorganisms and microbiome analysis. NOTE 2 International, national or regional regulations or requirements or multiples of them can also apply to specific topics covered in this document.

 

This document specifies requirements and gives recommendations for next generation sequencing (NGS) workflows for in vitro diagnostics and biomedical research. This document covers the pre-examination processes including human RNA isolation, sequencing library preparation, sequencing, sequence analysis and reporting of the examined sequences for diagnostic purposes from isolated RNA from, e.g. formalin-fixed and paraffin embedded tissues, fresh frozen tissues, fine needle aspirates (FNA), whole blood, circulating tumour cells (CTCs), exosomes and other extracellular vesicles, and circulating cell free RNA from plasma. NOTE 1 Typical applications include, but are not limited to, NGS for oncology and clinical genetics, certain single-cell analyses. This document addresses in vitro diagnostic examinations including laboratory developed examinations and is applicable to medical laboratories, molecular pathology laboratories and molecular genetic laboratories, in vitro diagnostic developers and manufacturers, biobanks as well as institutions and organizations performing biomedical research or sequencing services. This document is not applicable for in situ sequencing, forensic sequencing, sequencing of pathogens or microorganisms and microbiome analysis. NOTE 2 International, national or regional regulations or requirements or multiples of them can also apply to specific topics covered in this document.

 

1.1 Scope of EN 1993-6 (1) EN 1993-6 provides rules for structural design of crane supporting structures. (2) EN 1993-6 is applicable to crane supporting structures, especially to indoor and outdoor overhead crane runway beams, of: a) overhead travelling cranes, either: — top-mounted cranes; — underslung cranes; b) monorail hoist blocks. NOTE The principles of the design rules can be applied to supporting structures of other types of cranes making due allowance for differences in the crane-induced actions, if exist. For example, the design rules for supporting structures of the cranes listed in (2) assume that the horizontal crane loads occur randomly scattered along the runways in general. This assumption does not apply to other cranes such as travelling wall jib cranes. (3) EN 1993-6 does not apply to the tracks and suspensions of light crane systems conforming to EN 16851, see Figure 1.1. NOTE The standardized tracks and suspensions of light crane systems are considered as parts of the crane. [Figure 1.1 — Light crane system] (4) Additional rules are given for ancillary runway items including crane rails, structural end stops, surge connectors and surge girders and for runway supporting structures. (5) EN 1993-6 does not apply to cranes and all other moving parts. NOTE Provisions for cranes are given in EN 13001 (all parts) in general and for bridge and gantry cranes in EN 15011 in particular. 1.2 Assumptions (1) Unless specifically stated, EN 1990-1, EN 1991 (all parts) and EN 1993-1 (all parts) apply. (2) The design methods given in EN 1993-6 are applicable if — the execution quality and tolerances are as specified in EN 1090-2, and; — the construction materials and products used are as specified in the relevant parts of EN 1993, or in the relevant material and product specifications. (3) Following interfaces between hoisting device and its supporting structure are assumed: a) the top of crane rail for top-mounted cranes; b) the top of flange on which the crane or hoist block operates for underslung cranes and monorail hoist blocks; c) the support points as shown in Figure 1.1 for light crane systems.

 

This part of ISO/IEC 9798 specifies entity authentication mechanisms using zero-knowledge techniques: mechanisms based on identities and providing unilateral authentication; — mechanisms based on integer factorization and providing unilateral authentication; — mechanisms based on discrete logarithms with respect to numbers that are either prime or composite, and providing unilateral authentication; — mechanisms based on asymmetric encryption systems and providing either unilateral authentication or mutual authentication; — mechanisms based on discrete logarithms on elliptic curves and providing unilateral authentication. These mechanisms are constructed using the principles of zero-knowledge techniques, but they are not necessarily zero-knowledge according to the strict definition for every choice of parameters.

 

This document specifies requirements and gives recommendations for next generation sequencing (NGS) workflows. This document covers the pre-examination processes, human DNA (somatic and germline) isolation, sequencing library preparation, sequencing, sequence analysis and reporting of the examination of sequences for diagnostic purposes from isolated DNA from, e.g. formalin-fixed and paraffin embedded tissues, fresh frozen tissues, fine needle aspirates (FNA), whole blood, circulating tumour cells (CTCs), exosomes and other extracellular vesicles, circulating cell free DNA from plasma, and DNA from saliva. NOTE 1 Typical applications include, but are not limited to, NGS for oncology, pharmacogenomics and clinical genetics; approaches include panels (e.g. disease panels, exome panels, target gene panels and in silico panels), exome and whole genome sequencing, as well as certain epigenetics and certain single-cell analyses. This document is addressing in vitro diagnostic examinations including laboratory developed tests and is applicable to medical laboratories, molecular pathology laboratories and molecular genetic laboratories, in vitro diagnostic developers and manufacturers, biobanks as well as institutions and organizations performing biomedical research or sequencing services. This document is not applicable for in situ sequencing, DNA-mediated protein sequencing, forensic sequencing, sequencing of pathogens or microorganisms and microbiome analysis. NOTE 2 International, national or regional regulations or requirements or multiples of them can also apply to specific topics covered in this document.

 

This document specifies requirements and gives recommendations for next generation sequencing (NGS) workflows. This document covers the pre-examination processes, human RNA isolation, sequencing library preparation, sequencing, sequence analysis and reporting of the examination of sequences for diagnostic purposes from isolated RNA from, e.g. formalin-fixed and paraffin embedded tissues, fresh frozen tissues, fine needle aspirates (FNA), whole blood, circulating tumour cells (CTCs), exosomes and other extracellular vesicles, and circulating cell free RNA from plasma. NOTE 1 Typical applications include, but are not limited to, NGS for oncology and clinical genetics, certain single-cell analyses. This document is addressing in vitro diagnostic examinations including laboratory developed tests and is applicable to medical laboratories, molecular pathology laboratories and molecular genetic laboratories, in vitro diagnostic developers and manufacturers, biobanks as well as institutions and organizations performing biomedical research or sequencing services. This document is not applicable for in situ sequencing, forensic sequencing, sequencing of pathogens or microorganisms and microbiome analysis. NOTE 2 International, national or regional regulations or requirements or multiples of them can also apply to specific topics covered in this document.

 

1.1 Scope of EN 1994-1-1 (1) EN 1994-1-1 gives general rules for the design of steel and concrete composite structures and supplementary provisions specific for buildings. NOTE Specific rules for bridges are given in EN 1994-2. 1.2 Assumptions (1) The assumptions of EN 1990-1 apply to EN 1994-1-1. (2) In addition to the general assumptions of EN 1990-1, the assumptions given in EN 1992-1-1, EN 1992-1-2, and EN 1993-1-1 apply to this document. (3) EN 1994-1-1 is intended to be used in conjunction with EN 1990-1, EN 1991 (all parts), EN 1992-1-1, EN 1993 (all parts), EN 1997 (all parts), EN 1998 (all parts when steel and concrete composite structures are built in seismic regions), EN 1090-1, EN 1090-2, EN 1090-4, EN 13670 and ENs for construction products relevant to steel and concrete composite structures.

 

EN 1994-2 gives design rules for steel-concrete composite bridges or members of bridges, supplementary to the general rules given in EN 1994-1-1.

 

(1) EN 1994-1-2 gives rules for the design of steel-concrete composite structures for the accidental design situation of fire exposure. It only identifies differences from, or supplements to, rules for normal temperature design. (2) EN 1994-1-2 only applies to structures, or parts of structures, that are within the scope of EN1994-1-1 and are designed accordingly.

 

ISO 17078:2004 provides requirements for side-pocket mandrels used in the petroleum and natural gas industry. This part of ISO 17078 includes specifying, selecting, designing, manufacturing, quality control, testing, and preparation for shipping of side-pocket mandrels. This part of ISO 17078:2004 does not address nor include requirements for end connections between the side-pocket mandrels and the well conduit. The installation and retrieval of side-pocket mandrels is outside the scope of this part of ISO 17078:2004. Additionally, this part of ISO 17078:2004 does not include specifications for centre-set mandrels, or mandrels that employ or support tubing-retrievable flow control devices. This part of ISO 17078:2004 does not include gas-lift or any other flow-control valves or devices, latches, and/or associated wire line equipment that can or cannot be covered in other ISO specifications. The side-pocket mandrels to which this part of ISO 17078:2004 refers are independent devices that can accept installation of flow-control or other devices down-hole.

 

Within the context of the ISO/IEEE 11073 family of standards for device communication, a normative definition of communication between personal telehealth cardiovascular fitness and activity monitor devices and managers (e.g., cell phones, personal computers, personal health appliances, and set top boxes) is established in this standard in a manner that enables plug-and-play interoperability. Appropriate portions of existing standards are leveraged including ISO/IEEE 11073 terminology, information models, application profile standards, and transport standards. The use of specific term codes, formats, and behaviors in telehealth environments restricting optionality in base frameworks in favor of interoperability is specified. A common core of communication functionality for personal telehealth cardiovascular fitness and activity monitor devices is defined in this standard.

 

This document specifies the general requirements for sampling, preservation, handling, transport and storage of all water samples for physicochemical, chemical, hydrobiological and microbiological analyses and determination of radiochemical analytes and activities. Guidance on the validation of storage times of water samples is provided in ISO/TS 5667-25. This document is not applicable to water samples intended for ecotoxicological assays, biological assays (which is specified in ISO 5667-16), passive sampling (which is specified in ISO 5667-23) and microplastics (which is specified in ISO 5667-27). This document is particularly appropriate when samples cannot be analysed on site and have to be transported to a laboratory for analysis.

 

This document specifies a method whereby the dielectric properties of cured materials containing epoxy resin are determined at the microwave and millimetre wave frequencies (1 GHz to 80 GHz).

 

This document provides terms and definitions for microphysiological systems (MPS) and Organ-on-Chip (OoC). This document is applicable to all stakeholders of MPS and OoC within the fields of biotechnology, pharmacy, chemistry and other application fields.

 

1.1 This document specifies the requirements for materials, design, manufacture, testing inspection, safety equipment configuration and documentation (including instructions for first operation), for commonly-used types of gas-loaded accumulators and pressure vessels used to provide additional gas capacity for fluid power applications (see 1.2). 1.2 This document applies to the following types of components, defined as the pressure-containing envelope of gas-loaded accumulators: - bladder type; - diaphragm type; - piston type; - transfer type; - pressure vessels used to provide additional gas capacity. They consist of one or several parts joined together by a variety of mechanical means and by welding. 1.3 This document applies to gas-loaded accumulators which operate with the following conditions: - subject to an internal gauge pressure greater than 0,5 bar; - working temperature not lower than –50 °C and not higher than +200 °C; - containing all liquids and gases as defined in the European Legislation on Pressure Equipment, see Note. NOTE When the accumulator contains Group 1 liquids or gases, consideration relating to risks other than those required by the European Legislation on Pressure Equipment are not covered by this document and will be assessed separately.